Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management
Open Access
- 21 January 2021
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 11 (2), 136
- https://doi.org/10.3390/biom11020136
Abstract
In an era when cancer glycobiology research is exponentially growing, we are witnessing a progressive translation of the major scientific findings to the clinical practice with the overarching aim of improving cancer patients’ management. Many mechanistic cell biology studies have demonstrated that heparan sulfate (HS) glycosaminoglycans are key molecules responsible for several molecular and biochemical processes, impacting extracellular matrix properties and cellular functions. HS can interact with a myriad of different ligands, and therefore, hold a pleiotropic role in regulating the activity of important cellular receptors and downstream signalling pathways. The aberrant expression of HS glycan chains in tumours determines main malignant features, such as cancer cell proliferation, angiogenesis, invasion and metastasis. In this review, we devote particular attention to HS biological activities, its expression profile and modulation in cancer. Moreover, we highlight HS clinical potential to improve both diagnosis and prognosis of cancer, either as HS-based biomarkers or as therapeutic targets.Funding Information
- Fundação para a Ciência e a Tecnologia (POCI-01-0145-FEDER-007274)
This publication has 265 references indexed in Scilit:
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cellsLeukemia, 2011
- A role for heparan sulfate proteoglycans in Plasmodium falciparum sporozoite invasion of anopheline mosquito salivary glandsBiochemical Journal, 2011
- Growth factor-dependent branching of the ureteric bud is modulated by selective 6-O sulfation of heparan sulfateDevelopmental Biology, 2011
- Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signalingDevelopmental Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Heparan sulfate proteoglycans: A GAGgle of skeletal‐hematopoietic regulatorsDevelopmental Dynamics, 2008
- Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinomaHepatology, 2008
- Heparan sulphate proteoglycans fine-tune mammalian physiologyNature, 2007
- Basement membrane proteoglycans: from cellar to ceilingNature Reviews Molecular Cell Biology, 2005